Malignant melanotic nerve sheath tumor
- Authors: Agarkova E.I.1, Maximova N.A.1, Arzamastseva M.A.1, Ilchenko M.G.1, Shatova Y.S.1
-
Affiliations:
- National Medical Research Center of Oncology
- Issue: Vol 105, No 6 (2024)
- Pages: 1029-1036
- Section: Clinical experiences
- URL: https://journal-vniispk.ru/kazanmedj/article/view/311390
- DOI: https://doi.org/10.17816/KMJ629491
- ID: 311390
Cite item
Open Access
Access granted
Subscription Access
Abstract
Malignant melanotic nerve sheath tumor, previously melanotic schwannoma, is a rare peripheral nerve sheath tumor composed of melanin-producing Schwann cells, often clinically misdiagnosed as melanoma. It is an uncommon neoplasm with unpredictable biological behavior and varying treatments. Despite its histologic features indicative of benignity, including a low proliferative index, its clinical course is frequently malignant, with a high local recurrence rate and metastatic potential. The distinctive characteristics of malignant melanotic nerve sheath tumor include a relatively young patient age, signs of Carney complex, and psammoma bodies within the tumor. This study presents a case of a patient with malignant melanotic nerve sheath tumor located in the neck with a recurrent clinical course who underwent two surgical procedures. Microscopic and immunohistochemical evaluation of postoperative specimens showed positivity for melanoma markers, absence of psammoma bodies, and low mitotic activity. The clinical course of the disease was malignant, with recurrence developing in the postoperative scar. Diagnosing malignant melanotic nerve sheath tumor is radiologically and pathologically challenging. Multidisciplinary collaboration among the surgeon, radiologist, and pathologist; understanding the lesion’s anatomical context; and close attention to histopathologic findings are critical for establishing an accurate diagnosis.
Full Text
##article.viewOnOriginalSite##About the authors
Elena I. Agarkova
National Medical Research Center of Oncology
Email: agarkovaei82@mail.ru
ORCID iD: 0000-0001-9243-1665
SPIN-code: 3467-4388
MD, Cand. Sci. (Med.), Radiologist, Depart. of Radionuclide Therapy and Diagnostics
Russian Federation, Rostov-on-DonNatalya A. Maximova
National Medical Research Center of Oncology
Email: maximovanataly@mail.ru
ORCID iD: 0000-0002-0400-0302
SPIN-code: 1785-9046
MD, Dr. Sci. (Med.), Prof., Head of Depart., Depart. of Radionuclide Therapy and Diagnostics
Russian Federation, Rostov-on-DonMarina A. Arzamastseva
National Medical Research Center of Oncology
Email: marinaarz64@yandex.ru
ORCID iD: 0000-0002-1926-3463
SPIN-code: 7643-2081
MD, Cand. Sci. (Med.), Radiologist, Depart. of Radionuclide Therapy and Diagnostics
Russian Federation, Rostov-on-DonMaria G. Ilchenko
National Medical Research Center of Oncology
Author for correspondence.
Email: maria_ilchenko80@mail.ru
ORCID iD: 0000-0002-9126-0646
SPIN-code: 2856-7946
MD, Cand. Sci. (Med.), Researcher, Tumor Diagnostics Depart.
Russian Federation, Rostov-on-DonYuliana S. Shatova
National Medical Research Center of Oncology
Email: shat5@rambler.ru
ORCID iD: 0000-0002-1748-9186
SPIN-code: 8503-3573
MD, Dr. Sci. (Med.), Leading Researcher, Depart. of Soft Tissue and Bone Tumors
Russian Federation, Rostov-on-DonReferences
- Bublyevsky DV, Baranova OV, Evzikov GY, Korshunov AG, Shashkova EV. A case of primary-malignant tumor of the sheath of peripheral nerves affecting the roots of cauda equina. The Russian Journal of Neurosurgery. 2005;(4):62–64. (In Russ.) EDN: KALCOR
- Alexiev BA, Chou PM, Jennings LJ. Pathology of melanotic schwannoma. Arch Pathol Lab Med. 2018;142(12):1517–1523. doi: 10.5858/arpa.2017-0162-RA
- Osborn AG, Louis DN, Poussaint TY, Linscott LL, Salzman KL. The 2021 World Health Organization classification of tumors of the central nervous system: What neuroradiologists need to know. AJNR Am J Neuroradiol. 2022;43(7):928–937. doi: 10.3174/ajnr.A7462
- Nenashev EA, Rotin DL, Stepanian MA, Kadasheva AB, Cherekaev VA. Differential diagnosis between melanotic schwannoma of gasserian ganglion and metastatic melanoma of middle cranial fossa. Burdenko's Journal of Neurosurgery. 2012;76(2):58–64. (In Russ.) EDN: PDXQFR
- Chamoun RB, Whitehead WE, Dauser RC, Luerssen TG, Okcu MF, Adesina AM, Jea A. Primary disseminated intradural malignant peripheral nerve sheath tumor of the spine in a child: Case report and review of the literature. Pediatr Neurosurg. 2009;45(3):230–236. doi: 10.1159/000224621
- Torres-Mora J, Dry S, Li X, Binder S, Amin M, Folpe AL. Malignant melanotic schwannian tumor: A clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of “melanotic schwannoma”. Am J Surg Pathol. 2014;38(1):94–105. doi: 10.1097/PAS.0b013e3182a0a150
- Shields LB, Glassman SD, Raque GH, Shields CB. Malignant psammomatous melanotic schwannoma of the spine: A component of Carney complex. Surg Neurol Int. 2011;2:136. doi: 10.4103/2152-7806.85609
- Bakan S, Kayadibi Y, Ersen E, Vatankulu B, Ustundag N, Hasıloglu ZI. Primary psammomatous melanotic schwannoma of the spine. Ann Thorac Surg. 2015;99(6):e141–е143. doi: 10.1016/j.athoracsur.2015.02.060
- Georgiev GK, Todorov IV, Shamov TP, Krushovenski IV, Fakirova AD, Ilcheva BN, Georgiev IT, Georgiev ND, Prandjev VS, Eftimov TN. L3 rootlet recurrent melanocytic schwannoma — case report and literature review. Folia Med (Plovdiv). 2021;63(3):448–456. doi: 10.3897/folmed.63.e55295
- Kit OI, Zakondyrin DE, Rostorguev EE, Rostorguev VE, Maslov AA. Experience in surgical treatment of vertebral metastatic tumors of craniovertebral localization. South Russian Journal of Cancer. 2023;4(3):6–11. (In Russ.) doi: 10.37748/2686-9039-2023-4-3-1
Supplementary files
